Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cardioprotective effects of quercetin against ischemia-reperfusion injury are age-dependent

M. Bartekova, J. Radosinska, D. Pancza, M. Barancik, T. Ravingerova

. 2016 ; 65 (Suppl. 1) : S101-S107. (Advances in cardiovascular research)

Jazyk angličtina Země Česko

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17021017

Quercetin, a polyphenolic compound present in various types of food, has been shown to exert beneficial effects in different cardiac as well as non-cardiac ischemia/reperfusion (I/R) models in adult animals. However, there is no evidence about the effects of quercetin on I/R injury in non-mature animals, despite the fact that efficiency of some interventions against I/R is age-dependent. This study was aimed to investigate the effects of chronic quercetin treatment on I/R injury in juvenile and adult rat hearts. Juvenile (4-week-old) as well as adult (12-week-old) rats were treated with quercetin (20 mg/kg/day) for 4 weeks, hearts were excised and exposed to 25-min global ischemia followed by 40-min reperfusion. Functional parameters of hearts and occurrence of reperfusion arrhythmias were registered to assess the cardiac function. Our results have shown that quercetin improved post-ischemic recovery of LVDP, as well as recovery of markers of contraction and relaxation, +(dP/dt)max and -(dP/dt)max, respectively, in juvenile hearts, but not in adult hearts. Quercetin had no impact on incidence as well as duration of reperfusion arrhythmias in animals of both ages. We conclude that the age of rats plays an important role in heart response to quercetin treatment in the particular dose and duration of the treatment. Therefore, the age of the treated subjects should be taken into consideration when choosing the dose of quercetin and duration of its application in prevention and/or treatment of cardiovascular diseases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17021017
003      
CZ-PrNML
005      
20181120140146.0
007      
ta
008      
170623s2016 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933390 $2 doi
035    __
$a (PubMed)27643931
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Barteková, Monika $u Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic; Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Slovak Republic $7 xx0197134
245    10
$a Cardioprotective effects of quercetin against ischemia-reperfusion injury are age-dependent / $c M. Bartekova, J. Radosinska, D. Pancza, M. Barancik, T. Ravingerova
520    9_
$a Quercetin, a polyphenolic compound present in various types of food, has been shown to exert beneficial effects in different cardiac as well as non-cardiac ischemia/reperfusion (I/R) models in adult animals. However, there is no evidence about the effects of quercetin on I/R injury in non-mature animals, despite the fact that efficiency of some interventions against I/R is age-dependent. This study was aimed to investigate the effects of chronic quercetin treatment on I/R injury in juvenile and adult rat hearts. Juvenile (4-week-old) as well as adult (12-week-old) rats were treated with quercetin (20 mg/kg/day) for 4 weeks, hearts were excised and exposed to 25-min global ischemia followed by 40-min reperfusion. Functional parameters of hearts and occurrence of reperfusion arrhythmias were registered to assess the cardiac function. Our results have shown that quercetin improved post-ischemic recovery of LVDP, as well as recovery of markers of contraction and relaxation, +(dP/dt)max and -(dP/dt)max, respectively, in juvenile hearts, but not in adult hearts. Quercetin had no impact on incidence as well as duration of reperfusion arrhythmias in animals of both ages. We conclude that the age of rats plays an important role in heart response to quercetin treatment in the particular dose and duration of the treatment. Therefore, the age of the treated subjects should be taken into consideration when choosing the dose of quercetin and duration of its application in prevention and/or treatment of cardiovascular diseases.
650    _2
$a věkové faktory $7 D000367
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x terapeutické užití $7 D000975
650    _2
$a srdeční arytmie $x etiologie $x prevence a kontrola $7 D001145
650    _2
$a techniky in vitro $7 D066298
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a reperfuzní poškození myokardu $x komplikace $x prevence a kontrola $7 D015428
650    _2
$a quercetin $x terapeutické užití $7 D011794
650    _2
$a potkani Wistar $7 D017208
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Radošínská, Jana $7 _AN048690 $u Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic; Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Slovak Republic
700    1_
$a Pancza, Dezider $7 xx0137395 $u Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic
700    1_
$a Barančík, Miroslav $7 xx0089695 $u Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic
700    1_
$a Ravingerová, Táňa, $d 1951- $7 xx0248557 $u Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic
773    0_
$w MED00003824 $t Physiological research. Advances in cardiovascular research $x 1802-9973 $g Roč. 65, Suppl. 1 (2016), s. S101-S107
773    0_
$t Advances in cardiovascular research $g (2016), s. S101-S107 $w MED00196543
856    41
$u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20170623 $b ABA008
991    __
$a 20181120140241 $b ABA008
999    __
$a ok $b bmc $g 1236313 $s 981890
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 65 $c Suppl. 1 $d S101-S107 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $o Advances in cardiovascular research $x MED00003824
BMC    ##
$a 2016 $d S101-S107 $m Advances in cardiovascular research $x MED00196543
LZP    __
$b NLK118 $a Pubmed-20170623

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...